Integrated Machine Learning and Molecular Simulation-Guided Discovery of Novel Small-Molecule PD-L1 Inhibitors
Background/Objectives: The programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) immune checkpoint is a key therapeutic target in cancer immunotherapy, but small-molecule inhibition remains challenging due to its shallow and dynamic interaction interface. This study aimed to develop an artificial intelligence (AI)-...